The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 14, 2020

Filed:

Jul. 14, 2015
Applicant:

Fraunhofer-gesellschaft Zur Förderung Der Angewandten Forschung E.v., Munich, DE;

Inventors:

Andreas Weigert, Hofheim am Taunus, DE;

Javier Mora, Frankfurt am Main, DE;

Bernhard Brune, Schöneck, DE;

Christina Dillmann, Frankfurt, DE;

Michael John Parnham, Bad Soden am Taunus, DE;

Gerd Geisslinger, Bad Soden, DE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/52 (2006.01); C07K 14/54 (2006.01); G01N 33/68 (2006.01); G01N 33/50 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/54 (2013.01); G01N 33/5041 (2013.01); G01N 33/6869 (2013.01); A61K 38/00 (2013.01); G01N 2333/54 (2013.01); G01N 2500/10 (2013.01);
Abstract

The present invention pertains to an N-terminally truncated interleukin (IL)-38 protein, or functional variants thereof, as well as to nucleic acids and vectors encoding the truncated IL-38 peptide and recombinant cells comprising these nucleic acids or vectors. The invention shows that IL-38 is N-terminally processed and that the truncated version of the cytokine acts as an antagonist of immune activation in macrophages. This indicates a use of the truncated cytokine in the treatment and prevention of autoimmune disorders. The invention further provides pharmaceutical compositions comprising the truncated IL-38 protein, and method for screening modulators of the function of truncated IL-38.


Find Patent Forward Citations

Loading…